A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)

J. Michael Kilby, R. Pat Bucy, Donna Mildvan, Margaret Fischl, Jorge Santana-Bagur, Jeff Lennox, Chris Pilcher, Andrew Zolopa, Jody Lawrence, Richard B. Pollard, Raphaelle El Habib, David Sahner, Lawrence Fox, Evgenia Aga, Ronald J. Bosch, Ronald Mitsuyasu

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)'. Together they form a unique fingerprint.

Medicine & Life Sciences